The Utility of the Test of Memory Malingering Trial 1 in Differentiating Neurocognitive, Emotional, and Behavioral Functioning in a Pediatric Concussion Population.

OBJECTIVE: In concussion populations, suboptimal task engagement detected by performance validity tests (PVTs) has been associated with poorer neuropsychological scores and greater post-concussive symptoms (PCS). This study examined if Pass/Fail status on the Test of Memory Malingering-TOMM Trial 1-differentiated the neurocognitive, emotional, and behavioral profile of pediatric patients with concussion. METHOD: This study utilized archival data from 93 patients (mean age = 14.56 and SD = 2.01) with a history of concussion who were assessed at ~5-6 weeks post-injury (mean days = 40.27 and SD = 35.41). Individuals were divided into "Pass" and "Fail" groups based on TOMM Trial 1 performance. The testing battery included ACT, CPT-II and III, HVLT-R, WJ-III and IV ACH, ImPACT, BASC-2, and BRIEF. RESULTS: The overall pass rate on Trial 1 was 70% (mean = 46.04 and SD = 4.55). Findings suggested that a passing score on Trial 1 may be associated with adequate performance across the remaining two trials of the TOMM. The Fail group scored significantly lower across attention, memory, and processing speed measures when compared with the Pass group. On rating scales, significantly more concerns were endorsed with the Fail group for attention and executive functioning relative to the Pass group. Parents generally endorsed significantly more concerns for executive functioning when compared with their children's self-reported symptoms. There was a trend for the Fail group to report more PCS; however, they did not significantly differ from the Pass group for depression, anxiety, or somatization. CONCLUSIONS: This study highlights the importance of utilizing PVTs when evaluating concussion recovery.

Examination of the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF) validity and substantive scales in patients with electrical injury.

Objective: Electrical injury (EI) is a distinct subtype of traumatic injury that often results in a unique constellation of cognitive sequelae and unusual sensory experiences due to peripheral nervous system injury that are uncommon in general medical/neurological populations and have been unexplored with the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF). Method: This study examined performance patterns on MMPI-2-RF validity and substantive scales among 62 EI patients who underwent neuropsychological evaluation, of which 46 demonstrated valid symptom reporting and neurocognitive test performance via multiple independent validity indicators and were retained for analysis. Results: Valid EI patients scored significantly higher than the MMPI-2-RF normative sample on several validity scales with the largest effect sizes on F-r (Infrequent Responses), Fs (Infrequent Somatic Responses), FBS-r (Symptom Validity), and RBS (Response Bias), and ≥33% obtaining elevated scores on these scales per standard interpretive criteria. Review of item content on these scales revealed several reflect disturbances in sensation, physical functioning, and/or cognition that are not infrequent in this population. Further, MMPI-2-RF clinical profiles did not reveal generalized distress or noncredible over-reporting. Rather, similar to the MMPI-2, valid EI patients had a specific pattern related to physical/sensory symptoms and reduced positive emotions with elevations on restructured clinical (RC) scale 1 (somatic complaints), somatic/cognitive specific problem scales, and low positive emotions (RC2). Conclusions: Elevations on some MMPI-2-RF validity scale may capture some degree of actual EI sequela that neuropsychologists need to consider to prevent erroneously concluding that a credible EI patient is over-reporting when s/he is reporting bona fide, EI-related symptoms.